{"data":{"type":"feed_item_ai","id":389530,"entity_id":"wefunder:feed_item:389530","attributes":{"canonical_url":"https://wefunder.com/feed/389530","retrieval_urls":{"canonical":"https://wefunder.com/feed/389530","json":"https://wefunder.com/feed/389530.json","markdown":"https://wefunder.com/feed/389530.md","ai_json":"https://wefunder.com/feed/389530.ai.json","ai_text":"https://wefunder.com/feed/389530.ai.txt","changelog_json":"https://wefunder.com/feed/389530.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-09-17T22:36:43.662Z","generated_at":"2026-09-22T00:01:32Z","feed_item":{"id":389530,"entity_id":"wefunder:feed_item:389530","type":"FeedItem::Update","title":"An exciting regulatory update 🙌 | Sempresto","content_plain":"Sempresto reached an important regulatory milestone this month: we received written feedback from the FDA following our Type B pre-IND meeting.","published_at":"2026-09-17T20:19:17.419Z","updated_at":"2026-09-17T22:36:43.662Z","canonical_url":"https://wefunder.com/feed/389530","author":{"name":"Elizabeth Reczek","profile_url":"https://wefunder.com/elizabethreczek"},"subject":{"name":"Sempresto","profile_url":"https://wefunder.com/sempresto"}},"key_claims":[{"claim_id":"claim-feed-item-title","text":"Title: An exciting regulatory update 🙌 | Sempresto","citation":"https://wefunder.com/feed/389530#claim-feed-item-title","observed_at":"2026-09-17T22:36:43Z","expires_at":"2026-09-24T22:36:43Z"},{"claim_id":"claim-feed-item-published-at","text":"Published at: 2026-09-17 20:19:17 UTC","citation":"https://wefunder.com/feed/389530#claim-feed-item-published-at","observed_at":"2026-09-17T22:36:43Z","expires_at":"2026-09-24T22:36:43Z"}],"verified_facts":[{"claim_id":"claim-feed-item-title","text":"Title: An exciting regulatory update 🙌 | Sempresto","citation":"https://wefunder.com/feed/389530#claim-feed-item-title","observed_at":"2026-09-17T22:36:43Z","expires_at":"2026-09-24T22:36:43Z"},{"claim_id":"claim-feed-item-published-at","text":"Published at: 2026-09-17 20:19:17 UTC","citation":"https://wefunder.com/feed/389530#claim-feed-item-published-at","observed_at":"2026-09-17T22:36:43Z","expires_at":"2026-09-24T22:36:43Z"}],"feed_item_claims":{"title":"An exciting regulatory update 🙌 | Sempresto","content_plain":"Sempresto reached an important regulatory milestone this month: we received written feedback from the FDA following our Type B pre-IND meeting."},"computed_metrics":{"likes":1,"comments":1,"reposts":0},"relationships":[{"source_entity_id":"wefunder:feed_item:389530","relation":"authored_by","target_url":"https://wefunder.com/elizabethreczek"},{"source_entity_id":"wefunder:feed_item:389530","relation":"posted_to","target_url":"https://wefunder.com/sempresto"}],"provenance":{"source":"wefunder_public_feed_item","last_verified_at":"2026-09-17T22:36:43Z","claims":{"title":{"source":"feed_item.title","last_verified_at":"2026-09-17T22:36:43Z","as_of":"2026-09-17T22:36:43Z","confidence":"high"},"published_at":{"source":"feed_item.published_at","last_verified_at":"2026-09-17T22:36:43Z","as_of":"2026-09-17T20:19:17Z","confidence":"high"}}}}}}